Infertile patients may have a higher incidence of endometrial cancer (EC) compared with the general population.
OBJECTIVE:
Infertile patients may have a higher incidence of endometrial cancer (EC) compared with the general population. 1, 2 However, the prevalence of EC in infertile patients is still not clear, and, in the literature, there are only a few studies on the aforementioned topic. 3 In this study, we aimed to investigate the prevalence of endometrial atypical hyperplasia (AH)/endometrial intraepithelial neoplasia (EIN) and EC in women who were seen for evaluation of infertility.
STUDY DESIGN:
This retrospective single-institution cohort study was carried out at the Reproductive Endocrinology and Infertility Department of Baskent University in Ankara, was approved by the Institutional Review Board of Baskent University (KA18/160), and was performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki. We identified infertile patients with a primary or a secondary diagnosis of female infertility according to the International Classification of Diseases, 10th edition (N97.0-9). Diagnoses of EC or AH/EIN during infertility follow-up evaluation and clinical information were extracted from the medical records of this cohort.
RESULTS:
Between 2011 and 2018, 10,331 women (mean age, 33; range, 18e50 years) at our clinic underwent routine infertility investigations that included transvaginal ultrasonography, hysterosalpingography, and pelvic examination. Approximately 54% of them (5560 women) had abnormal history or findings (such as abnormal intermenstrual bleeding, repeated implantation failure, recurrent pregnancy loss, increased endometrial thickness or suspicion of endometrial polyp, or submucosal myoma or uterine septum), which prompted subsequent hysteroscopy and endometrial biopsy. Resection of polyps, myomas, and septum were performed where necessary; even if no lesion were detected, routine endometrial biopsy with pathologic testing was performed to exclude chronic endometritis. Among women who underwent hysteroscopy plus endometrial biopsy that was prompted by abnormal endometrial findings on transvaginal ultrasound imaging that was conducted in the course of an infertility investigation, 0.18% of the women (10/5560) were diagnosed with EC, and 0.3% of the women (17/5560) were diagnosed with AH/EIN ( Figure) . The median age, mean body mass index, and mean duration of infertility were 30 years, 28 kg/m 2 , and 45.7 months in women with AH/EIN, respectively, and 32 years, 28.3 kg/m 2 , and 25 months in women with EC, respectively. The conditions that were associated with infertility in women with AH/EIN were poor ovarian reserve (n¼9; 52.9%), polycystic ovary syndrome (n¼5; 29.4%), and unexplained infertility (n¼3; 17.6%) and in women with EC were poor ovarian reserve (n¼1; 10%), polycystic ovary syndrome (n¼7; 70%), tubal factors (n¼1; 10%), and unexplained infertility (n¼1; 10%).
CONCLUSION:
Our results showed 3 important findings. First, to the best of our knowledge, this study constitutes 1 of the 2 largest series of incidentally diagnosed EC and AH/EIN in infertility patients worldwide.
3 Furthermore, our study reports the highest prevalence of EC and AH/EIN among similar studies. Second, we observed a higher prevalence of EC and AH/EIN in our infertile cohort than the general population compared with the literature. 4, 5 Third and interestingly, more women with AH/EIN were diagnosed with poor ovarian reserve than polycystic ovary syndrome, which suggests that chronic anovulation may not be the main cause of the increased neoplastic risk in infertile patients. Detection of precancerous lesions in patients with poor ovarian reserve leads us to consider other possible causes such as phosphatase and tensin homolog gene mutations, which also leads to diminished ovarian reserves and may cause endometrial cancerous and precancerous lesions. 6, 7 Given the high prevalence of EC and AH/EIN in this infertile cohort, clinicians should consider evaluating endometrial disease in the course of infertility evaluation, in particular in those women with an abnormal history or abnormal ultrasound findings. This study reveals new important findings about the prevalence of EC and AH/EIN in an infertile cohort that could be used for systematic reviews and meta-analysis.
FIGURE
Flowchart of all infertile patients who underwent routine infertility investigations: diagnosis and follow up Only 1 patient with endometrial atypical hyperplasia/intraepithelial neoplasia failed to attend to the regular follow-up visits during medical treatment after the diagnosis. Two patients with endometrial cancer failed to attend to the regular follow-up visits during medical treatment. One of the 2 patients with endometrial cancer did not respond to medical treatment in 9 months and failed to attend to the regular follow-up visits. In the other patient with endometrial cancer, recurrence was detected after 18 months, and a second course of medical therapy was performed; however, this patient failed to attend follow-up visits during second course medical therapy as well. Recurrence was detected additionally in only 1 patient with endometrial cancer (20%). Recurrence was detected in this patient after 15 months, and a second course of medical therapy was performed, which resulted in complete response after 7 months of therapy. There was no recurrence in the patients with endometrial atypical hyperplasia/endometrial intraepithelial neoplasia. Spontaneous pregnancy was achieved in 6 patients; 3 pregnancies in patients with endometrial cancer and 3 pregnancies in patients with endometrial atypical hyperplasia/endometrial intraepithelial neoplasia. Miscarriage within the first trimester occurred in 2 patients of the patients with endometrial cancer, whereas there was no miscarriage in the patients with endometrial atypical hyperplasia/endometrial intraepithelial neoplasia. One full-term infant was delivered by a patient with endometrial cancer, whereas 3 full-term infants were delivered by patients with endometrial atypical hyperplasia/endometrial intraepithelial neoplasia. Assisted reproductive technology was performed in 2 patients with endometrial cancer (intracytoplasmic sperm injection or in vitro fertilization) and 5 patients with endometrial atypical hyperplasia/endometrial intraepithelial neoplasia (intracytoplasmic sperm injection or in vitro fertilization¼4, intrauterine insemination¼1). One pregnancy was achieved via in vitro fertilization in a patient with endometrial cancer; this pregnancy resulted in first-trimester miscarriage. Three pregnancies were achieved via intracytoplasmic sperm injection or in vitro fertilization in patients with endometrial atypical hyperplasia/endometrial intraepithelial neoplasia; 2 of these pregnancies resulted in delivery, and 1 of them is an ongoing pregnancy.
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